CTLA4 and colorectal cancer: For example, combinatorial blockage of cytotoxic T lymphocyte associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) checkpoint receptors led to increased progression-free survival (PFS) and overall survival (OS) rates in MSI colorectal cancer patients19,20.